Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Garetosmab

COURAGE

Regeneron · Phase 2 · Active, not recruiting · Enrollment 1005

NCT06299098

ArmPopulationDoseWeeksEstimandWeight change
PlaceboObesity or overweightn/rn/rn/rn/r
TrevogrumabObesity or overweightn/rn/rn/rn/r
Arm A0Obesity or overweightn/rn/rn/rn/r
Arm A1Obesity or overweightn/rn/rn/rn/r
Arm B0Obesity or overweightn/rn/rn/rn/r
Arm B1Obesity or overweightn/rn/rn/rn/r
Arm C0Obesity or overweightn/rn/rn/rn/r
Arm C1Obesity or overweightn/rn/rn/rn/r
Arm D0Obesity or overweightn/rn/rn/rn/r
Arm D1Obesity or overweightn/rn/rn/rn/r
Arm 1Obesity or overweightn/rn/rn/rn/r
Arm 2Obesity or overweightn/rn/rn/rn/r
Arm 3Obesity or overweightn/rn/rn/rn/r